AlzChem Group AG (ACT1)

Currency in EUR
158.00
0.00(0.00%)
Delayed Data·
ACT1 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
158.00158.00
52 wk Range
123.20201.40
Key Statistics
Bid/Ask
158.10 / 158.70
Prev. Close
158
Open
158
Day's Range
158-158
52 wk Range
123.2-201.4
Volume
-
Average Volume (3m)
130
1-Year Change
1.9355%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACT1 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

AlzChem Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

AlzChem Group AG Earnings Call Summary for H1/2026

  • AlzChem H1 2026 revenue rose 6% YoY to EUR 304M, beating forecast by 6.77%; EBITDA jumped 14% to EUR 64.5M with margin expanding to 21.2%.
  • Specialty Chemicals drove growth with revenue up 10% and EBITDA up 19%, now representing 70% of group sales versus 67% prior year.
  • Company reaffirmed FY2026 guidance of EUR 600M revenue and EUR 126M EBITDA, warning H2 EBITDA will be lower due to ramp-up costs and furnace restart.
  • Management announced U.S. nitroguanidine plant in South Carolina targeting 2027 construction and 2029 production, with potential EUR 100M revenue at capacity.
  • Stock rose 1.86% to $175.1 pre-market; CEO cited strong creatine demand 'growing like hell' while agriculture segment remains pressured by weak farmer economics.
Last Updated: 2026-07-30, 04:58 a/m
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
1.66 / --
Revenue / Forecast
155.25M / 145.4M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.70%
Dividend Yield
1.33%
Industry Median 2.32%
Annualized payout
2.10
Paid annually
5-Years Growth
+22.22%
Growth Streak

ACT1 Income Statement

Compare ACT1 to Peers and Sector

Metrics to compare
ACT1
Peers
Sector
Relationship
P/E Ratio
23.4x12.4x3.6x
PEG Ratio
1.350.010.00
Price/Book
5.9x1.1x1.6x
Price / LTM Sales
2.7x0.7x1.3x
Upside (Analyst Target)
28.3%9.4%40.7%
Fair Value Upside
Unlock6.7%1.4%Unlock

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS – BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Industry
Chemicals
Employees
1680
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.79M27.59%430.39M
Other Institutional Investors
3.58M35.33%551.11M
Public Companies & Retail Investors
3.75M37.09%578.57M
Total
10.12M100.00%1.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Four Two Na GmbH10.19%1,031,880159,013
CSG FIN a.s.9.25%936,223144,272

People Also Watch

11.714
BMPS
+0.29%
77.800
SMHNn
-2.14%
67.400
FRAG
-1.75%
18.000
EVKn
+0.73%
16.995
ENAG
+0.56%

FAQ

What Is the AlzChem Group (ACT1) Stock Price Today?

The AlzChem Group stock price today is 158.00 EUR.

What Stock Exchange Does AlzChem Group Trade On?

AlzChem Group is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for AlzChem Group?

The stock symbol for AlzChem Group is "ACT1."

Does AlzChem Group Pay Dividends? What’s The Current Dividend Yield?

The AlzChem Group dividend yield is 1.33%.

What Is the AlzChem Group Market Cap?

As of today, AlzChem Group market cap is 1.60B EUR.

What Is AlzChem Group's Earnings Per Share (TTM)?

The AlzChem Group EPS (TTM) is 6.70.

When Is the Next AlzChem Group Earnings Date?

AlzChem Group will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is ACT1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AlzChem Group Stock Split?

AlzChem Group has split 2 times.

How Many Employees Does AlzChem Group Have?

AlzChem Group has 1680 employees.

What is the current trading status of AlzChem Group (ACT1)?

As of Aug 05, 2026, AlzChem Group (ACT1) is trading at a price of 158.00 EUR, with a previous close of 158.00 EUR. The stock has fluctuated within a day range of 158.00 EUR to 158.00 EUR, while its 52-week range spans from 123.20 EUR to 201.40 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.